About this trial
During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
women undergoing IVF/ICSI or frozen embryo transfers (FET) that less than 40 years old.
Disqualifiers
day 3 transfers
Trial design
Parallel
Treatments tested in this trial
GnRH
Drugsingle shot of GnRH agonist
placebo
Drugplacebo
Treatment groups
Trial outcomes
Primary outcomes
Live birth per transfer
Secondary outcomes
implantation rates
clinical pregnancy
rates of OHSS
Sponsors and contacts
Click on the lead sponsor to view all of their trials.